NCT07245056

Brief Summary

Since early-onset preeclampsia (EOPE) is commonly associated with inadequate placentation, placental insufficiency, chronic fetal hypoxia, oxidative stress, and heightened inflammation, these pathological processes may adversely affect hippocampal neuronal development and maturation of axonal pathways such as the fornix. These mechanisms support our hypothesis that fetal fornix and hippocampus dimensions may be reduced in pregnancies complicated by EOPE, forming the scientific basis of our study. Previous research has suggested a potential link between preeclampsia (PE) and altered neurocognitive development. However, no studies to date have specifically evaluated the relationship between EOPE and fetal fornix or hippocampus dimensions. Therefore, the objective of our study is to assess fetal fornix and hippocampus measurements in pregnant women with early-onset preeclampsia compared with healthy controls.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Dec 2025Aug 2026

First Submitted

Initial submission to the registry

November 15, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

November 15, 2025

Last Update Submit

December 21, 2025

Conditions

Keywords

fetal brainfornixhippocampusearly-onset preeclampsia

Outcome Measures

Primary Outcomes (1)

  • Fetal fornix-hippocampus complex (FHC) dimensions (mm)

    Measurement of fetal fornix-hippocampus complex (FHC) length and hippocampus height using two-dimensional ultrasonography (2D-US) in pregnancies complicated by early-onset preeclampsia (EOPE) compared with healthy controls. Unit of Measure: Millimeters (mm) Measurement Tool: Two-dimensional ultrasonography (2D-US)

    Until completion of participant recruitment (approximately 7 months).

Secondary Outcomes (1)

  • Correlation between fetal FHC and hippocampus height measurements and composite adverse perinatal outcomes

    Until completion of participant recruitment (approximately 7 months).

Study Arms (1)

One arm (fetal FHC measurements for EOPE and control groups)

OTHER

One arm for fetal fornix and hippocampus complex (FHC) measurements on early-onset preeclampsia (EOPE) and control groups

Other: FHC dimensions in EOPE and control groups

Interventions

Fetal fornix and hippocampus complex (FHC) dimension changes on EOPE and control groups

One arm (fetal FHC measurements for EOPE and control groups)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18-45 years
  • Gestational age between 20 and 34 weeks
  • Diagnosis of early-onset preeclampsia (EOPE)
  • Singleton pregnancy

You may not qualify if:

  • Multiple pregnancies
  • Presence of chronic or significant comorbid conditions other than maternal early-onset preeclampsia, including: Chronic, mental, or physical illnesses, severe renal, hepatic, or gastrointestinal acute or chronic inflammatory diseases, hyperthyroidism or hypothyroidism, chronic hypertension, type 1 or type 2 diabetes mellitus, history of polycystic ovary syndrome (PCOS), history of malignancy
  • Fetal congenital or chromosomal anomalies
  • Chronic medication use
  • Tobacco or alcohol use during pregnancy
  • Maternal late-onset preeclampsia (≥34 weeks gestation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

RECRUITING

Related Publications (8)

  • Zhang H, Lin J, Zhao H. Impacts of Maternal Preeclampsia Exposure on Offspring Neuronal Development: Recent Insights and Interventional Approaches. Int J Mol Sci. 2024 Oct 15;25(20):11062. doi: 10.3390/ijms252011062.

    PMID: 39456854BACKGROUND
  • Johnson AC, Li Z, Orfila JE, Herson PS, Cipolla MJ. Hippocampal network dysfunction as a mechanism of early-onset dementia after preeclampsia and eclampsia. Prog Neurobiol. 2021 Apr;199:101938. doi: 10.1016/j.pneurobio.2020.101938. Epub 2020 Oct 29.

    PMID: 33130230BACKGROUND
  • Johnson AC, Tremble SM, Cipolla MJ. Experimental Preeclampsia Causes Long-Lasting Hippocampal Vascular Dysfunction and Memory Impairment. Front Physiol. 2022 May 9;13:889918. doi: 10.3389/fphys.2022.889918. eCollection 2022.

    PMID: 35615682BACKGROUND
  • Sadeghi A, Asghari H, Hami J, Mohasel Roodi M, Mostafaee H, Karimipour M, Namavar M, Idoon F. Volumetric investigation of the hippocampus in rat offspring due to diabetes in pregnancy-A stereological study. J Chem Neuroanat. 2019 Nov;101:101669. doi: 10.1016/j.jchemneu.2019.101669. Epub 2019 Aug 20.

    PMID: 31442582BACKGROUND
  • Arica G, Davutoglu EA, Buldum D, Kucuksuleymanoglu D, Najmeddin S, Madazli R. Fetal Fornix-Hippocampus Complex and Hippocampus Height Measurements Between 18 and 24 Weeks of Gestation and the Effect of Maternal Iron Deficiency Anemia. J Clin Ultrasound. 2025 Jul-Aug;53(6):1288-1295. doi: 10.1002/jcu.24008. Epub 2025 Apr 16.

  • Gindes L, Weissmann-Brenner A, Weisz B, Zajicek M, Geffen KT, Achiron R. Identification of the fetal hippocampus and fornix and role of 3-dimensional sonography. J Ultrasound Med. 2011 Dec;30(12):1613-8. doi: 10.7863/jum.2011.30.12.1613.

  • Sahin NE, Alici Davutoglu E, Arica G, Madazli R. Identification of bilateral fornix and hippocampus in fetuses between 18-36 gestational weeks and establishment of nomograms using ultrasonography. Arch Gynecol Obstet. 2025 Aug;312(2):627-634. doi: 10.1007/s00404-025-08061-z. Epub 2025 May 23.

  • Toprak E, Sayal HB. Ultrasonographic imaging of the fetal hippocampus. Arch Gynecol Obstet. 2024 May;309(5):1943-1949. doi: 10.1007/s00404-023-07093-7. Epub 2023 Jun 9.

MeSH Terms

Conditions

Pre-Eclampsia

Interventions

eosinylphosphatidylethanolamineControl Groups

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Seyit A Erol, MD

    Ankara Etlik City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seyit A Erol, MD

CONTACT

Kadriye Yakut Yucel, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, MD

Study Record Dates

First Submitted

November 15, 2025

First Posted

November 24, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

The data that support the findings of this study are available from the central contact person, upon reasonable request.

Locations